Iambic Therapeutics, Inc. (NASDAQ:IAM) IPO
IPO
Priced at US$16.00 a share on Oct 14, 2026.
- Price
- US$16.00 a share
- Shares offered
- 9,375,000 shares of common stock
- Offering size
- US$150 million
- Underwriters' option
- Up to 1,406,250 more shares
- Listing
- IAM on the Nasdaq Global Select Market
- Underwriters
- J.P. Morgan, Jefferies, BofA Securities, Citigroup · In the order on the cover
- Shares delivered
- On or about Oct 16, 2026
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jul 24, 2026 |
| Filed publicly | Sep 21, 2026 |
| Amended once | Oct 8, 2026 |
| Shares registered with an exchange | Oct 13, 2026 |
| Declared effective by the SEC | Oct 14, 2026 |
| Final prospectus, with the price | Oct 15, 2026 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Oct 15, 2026 |
| EFFECT · Notice that a registration is effective | Oct 14, 2026 |
| CERT · Exchange's certificate of listing | Oct 14, 2026 |
| 8-A12B · Registration of shares for listing on an exchange | Oct 13, 2026 |
| S-1/A · Registration statement, amended | Oct 8, 2026 |
| S-1 · Registration statement | Sep 21, 2026 |
| DRS/A · Draft registration statement, amended | Aug 28, 2026 |
| DRS · Draft registration statement | Jul 24, 2026 |
From the cover of the final prospectus (424B4) filed Oct 15, 2026